NYXH Stock Nasdaq

Stocks

End-of-day quote Nasdaq			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

10/05/22	Nyxoah's Q1 Loss Widens, Revenue Increases	MT
21/04/22	Oppenheimer Starts Nyxoah at Outperform With $30 Price Target	MT

10/05/22	Nyxoah's Q1 Loss Widens, Revenue Increases	MT
21/04/22	Oppenheimer Starts Nyxoah at Outperform With $30 Price Target	MT
06/04/22	Wolfe Research Starts Nyxoah at Peer Perform With $21 Price Target	MT
28/03/22	Piper Sandler Adjusts Price Target on Nyxoah to $30 From $40, Reiterates Overweight Rating	MT
05/10/21	NYXH : Nyxoah's Genio System Obtains CE-Mark Indication Approval to Treat Complete Concentric Collapse	MT
14/09/21	NYXH : Nyxoah Secures Breakthrough Therapy Designation for Genio Nerve Stimulation Device	MT
31/08/21	NYXH : Nyxoah Reports Wider Loss in H1	MT
27/07/21	NYXH : Stifel Initiates Nyxoah With Buy Rating	MT
02/07/21	NYXH : Belgium's Nyxoah Shares Rise in Stock Market Debut	MT
02/07/21	NYXH : Nyxoah Prices US IPO at $30 Per Share	MT

21/04/22	Oppenheimer Starts Nyxoah at Outperform With $30 Price Target	MT
06/04/22	Wolfe Research Starts Nyxoah at Peer Perform With $21 Price Target	MT
28/03/22	Piper Sandler Adjusts Price Target on Nyxoah to $30 From $40, Reiterates Overweight Rating	MT
27/07/21	NYXH : Stifel Initiates Nyxoah With Buy Rating	MT

09/05/22	Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Premier Trimestre 2022
06/05/22	Nyxoah nomme Raymond Cohen et Virginia Kirby pour la nomination à son Conseil d'Administration
28/04/22	Nyxoah Publiera ses Résultats Financiers pour le Premier Trimestre le 9 mai et Organisera une Conférence Téléphonique le 10 mai 2022
11/03/22	Nyxoah Participera à la 32ème Oppenheimer Annual Healthcare Conference
08/03/22	Nyxoah présentera les données de BETTER SLEEP et organisera des événements pour les médecins lors du World Sleep Congress 2022

Employees

Sector